Inventor
Rubina PARMAR
Inventor
US
Overview
Patents· 7 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes33%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations33%
C12NMicroorganisms or enzymes33%
PatentTitleYear
12,385,043Modified double-stranded RNA agents202512,385,044Modified double-stranded RNA agents202512,378,553Modified double-stranded RNA agents202512,168,767Modified double-stranded RNA agents202411,549,109Modified double-stranded RNA agents202311,427,822Modified double-stranded RNA agents202211,401,517Modified double-stranded RNA agents2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2025Patents assigned to ALNYLAM PHARMACEUTICALS INC (7)· patent assignee history
2022–2025Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ALNYLAM PHARMACEUTICALS INC | 7 | 2022–2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 7 | 2022–2025 |